recent articles
LINKÖPING, Sweden, April 8, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) signs distribution agreement with pathology AI vendor Paige.AI (Paige). The applications from Paige will be...
Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI...
Paige: AI-Assisted Diagnosis Across the Esophagus, Stomach, Duodenum, and Colorectum—Designed to Detect and Assess Disease Severity in Over 40 GI-Related Conditions NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI...
Aiforia, a trusted provider of deep learning artificial intelligence (AI) solutions for pathology and Paige, a leader in next-generation AI technology have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI*...
SPOKANE, Wash. and NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Gestalt, a leader in digital pathology solutions, and Paige, the leader in next-generation AI technology for pathology, are excited to announce a strategic partnership to integrate...
Paige to participate with PathPresenter at Pathology Visions preconference workshop MONTVILLE, NJ / ACCESSWIRE / October 16, 2024 / PathPresenter, a comprehensive enterprise pathology workflow platform known for its secure, scalable,...